文献速递临床生化临床免疫

库欣综合征皮质醇测定:免疫法还是质谱法?

Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?
PubMed 文献 · Ann Lab Med · 2020-01-01

本综述对比了免疫法与质谱法测定皮质醇在库欣综合征(CS)筛查中的差异,指出免疫法与内源性类固醇交叉反应导致唾液和尿液结果严重不准,但初步证据提示免疫法筛查CS的临床敏感性可能与质谱法相似;质谱法结果更准确、实验室间变异更小且避免假阳性,还能识别外源性皮质醇或评估地塞米松水平,并可用于区分CS亚型。

要点

  • 免疫法测唾液和尿液皮质醇因交叉反应结果严重不准。
  • 初步证据提示免疫法筛查CS的临床敏感性可能与质谱法相似。
  • 质谱法更准确、变异小、避免假阳性,可识别外源性皮质醇。

核心结论

  • 免疫法测唾液和尿液皮质醇因交叉反应严重不准,但筛查CS的临床敏感性初步证据显示可能与质谱法相似。
  • 质谱法结果更准确、实验室间变异更小且避免假阳性,并能应对识别外源性皮质醇等诊断挑战。

研究设计与样本

  • 综述,聚焦免疫法与质谱法测定皮质醇在库欣综合征筛查中的差异。

主要发现

  • 皮质醇代谢特性及免疫法特异性不足导致两法差异明显,且高度依赖所测生物学基质。
  • 免疫法与内源性类固醇交叉反应导致唾液和尿液皮质醇测定结果严重不准。
  • 初步证据提示免疫法筛查CS的临床敏感性可能与质谱法相似。
  • 质谱法可识别外源性皮质醇或同时评估抑制试验中地塞米松水平。
  • 综合质谱法分析多种类固醇代谢物可能有助于区分CS不同亚型。

临床怎么用

  • 理解两法差异来源对解释皮质醇结果至关重要。
  • 质谱法可提供更准确结果并减少实验室间变异,避免假阳性。

局限性

  • 综述提及需讨论影响皮质醇测定变异的主要分析前因素及其对结果可靠性的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Determination of cortisol levels in the urine (24 hours urine free cortisol), saliva (late-night), or serum (total cortisol after dexamethasone suppression) is recommended to screen for Cushing's syndrome (CS). This review focuses on the differences between the frequently used cortisol-antibody immunoassay-based methods and the highly specific mass-spectrometry-based methods that are progressively being employed in clinical laboratories for CS screening. The particular characteristics of cortisol metabolism and the lack of specificity of the immunoassays cause marked differences between both methods that are in turn highly dependent on the biological matrix, in which the cortisol is measured. Understanding the origin of these differences is essential for the interpretation of these results. Although cross-reactivity with endogenous steroids leads to grossly inaccurate results of immunoassay measurements of cortisol in the saliva and urine, preliminary evidence suggests that the clinical sensitivity of CS screening using immunoassays may be similar to CS screening using mass spectrometry. However, mass spectrometry offers more accurate results and considerably reduced variation across laboratories, while avoiding false-positive results. Moreover, mass spectrometry can overcome some common diagnostic challenges, such as identification of exogenous corticosteroids or simultaneous assessment of appropriate dexamethasone levels in suppression tests. Further, comprehensive mass spectrometry-based profiling of several steroid metabolites may be useful for discriminating among different subtypes of CS. Finally, this review discusses the main preanalytical factors that could cause variations in cortisol measurements and their influence on the reliability of the results.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Casals G, Hanzu FA. Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry? Ann Lab Med. 2020. PMID: 32067427. doi:10.3343/alm.2020.40.4.285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。